Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$25.82M
Current Assets
2025 Q3
$12.65M
Current Liabilities
2025 Q3
$16.02M
Current Ratio
2025 Q3
78.99%
Total Assets
2025 Q3
$13.08M
Total Liabilities
2025 Q3
$16.02M
Book Value
2025 Q3
-2.942M
Cash
2025 Q3
$11.36M
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$3.660M

Stock Price

Loading...
Market Cap: $234.71 Million

About NervGen Pharma Corp

The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-03-13.

Industry: Pharmaceutical Preparations

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support